The eIF4A Inhibitor Silvestrol Blocks the Growth of Human Glioblastoma Cells by Inhibiting AKT/mTOR and ERK1/2 Signaling Pathway

Table 2

Clinical information of the patients in this study.

Patient	Sex	Age (y)	Location	Pathological type	WHO grade
1	M	21	Cerebellum	Pilocytic astrocytoma	I
2	M	8	Cerebellum	Pilocytic astrocytoma	I
3	M	15	Cerebellum	Pilocytic astrocytoma	I
4	M	31	Sellar region	Capillary hemangioblastoma	I
5	M	18	Cerebellum	Pilocytic astrocytoma	I
6	F	37	Insula	Diffuse astrocytic glioma	II
7	M	37	Frontal lobe	Oligodendroglioma	II
8	M	50	Frontal lobe	Gemistocytic astrocytoma	II
9	F	68	Frontal lobe	Oligodendroglioma	II
10	M	64	Frontal lobe	Oligodendroglioma	II
11	M	43	Frontal lobe	Anaplastic astrocytoma	III
12	M	60	Frontal lobe	Anaplastic astrocytoma	III
13	M	63	Temporal lobe	Anaplastic astrocytoma	III
14	M	32	Frontal lobe	Anaplastic oligodendroglioma	III
15	F	49	Temporal lobe	Anaplastic astrocytoma	III
16	M	49	Parietal lobe	Glioblastoma	IV
17	M	65	Parietal lobe	Glioblastoma	IV
18	F	58	Temporal lobe	Glioblastoma	IV
19	F	57	Temporal lobe	Glioblastoma	IV
20	F	34	Temporal lobe	Glioblastoma	IV